To: U.S. Food and Drug Administration (FDA) / Center for Devices and Radiological Health (CDRH)
Cc: Department of Defense (DoD) / Defense Advanced Research Projects Agency (DARPA)

Request:

Requesting any and all documents, research proposals, internal communications, regulatory filings, or interagency agreements referencing Lovense (including all subsidiaries and affiliated entities) in relation to the development, testing, or deployment of internet-connected sexual wellness devices incorporating embedded sensors, wireless modules, or biometric data collection, from January 1, 2005 to present.

This includes:
	•	Correspondence between Lovense and federal agencies regarding device safety, efficacy, or classified use cases related to behavioral or physiological modulation.
	•	Documentation of experiments, clinical trials, or consumer testing involving remote-controlled or app-connected sexual devices with behavioral, neurological, or biometric endpoints.
	•	Reports or assessments on the use of teledildonics for continuous monitoring, data telemetry, or integration with neurotechnology-linked platforms.
	•	Internal or external communications on export controls, foreign partnerships, or technology transfer related to sensor-enabled sexual devices.
	•	Records concerning potential misuse scenarios, including surveillance, non-consensual experimentation, or weaponization of intimate biometric data.
	•	Contracts, grants, or cooperative research and development agreements (CRADAs) involving Lovense and agencies such as DARPA, IARPA, or DoD medical branches.

Keywords: Lovense, teledildonics, sextech, internet-connected device, sexual wellness sensors, biometric telemetry, behavioral modulation, remote programming, DARPA, CDRH


///////////


To: U.S. Food and Drug Administration (FDA) / Center for Devices and Radiological Health (CDRH)
Cc: Department of Defense (DoD) / Defense Advanced Research Projects Agency (DARPA)

Request:

Requesting any and all documents, research proposals, internal communications, regulatory filings, or interagency agreements referencing Lovense and/or Standard Innovation (We-Vibe) in relation to the development, testing, or deployment of internet-connected sexual wellness devices incorporating embedded sensors, wireless modules, or biometric data collection, from January 1, 2005 to present.

This includes:
	•	Correspondence between manufacturers and federal agencies regarding device safety, efficacy, or classified use cases related to behavioral or physiological modulation.
	•	Documentation of experiments, clinical trials, or consumer testing involving remote-controlled or app-connected sexual devices with behavioral, neurological, or biometric endpoints.
	•	Reports or assessments on the use of teledildonics for continuous monitoring, data telemetry, or integration with neurotechnology-linked platforms.
	•	Internal or external communications on export controls, foreign partnerships, or technology transfer related to sensor-enabled sexual devices.
	•	Records concerning potential misuse scenarios, including surveillance, non-consensual experimentation, or weaponization of intimate biometric data.
	•	Contracts, grants, or cooperative research and development agreements (CRADAs) involving Lovense, Standard Innovation, and agencies such as DARPA, IARPA, or DoD medical branches.

Keywords: Lovense, We-Vibe, Standard Innovation, teledildonics, sextech, internet-connected device, sexual wellness sensors, biometric telemetry, behavioral modulation, remote programming, DARPA, CDRH


